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Abstract
We suggest a cure-mixture model to analyze bivariate time-to-event data, as motivated by the
paper of Chatterjee and Shih (2001, Biometrics 57, 779 - 786), but with a simpler estima-
tion procedure and the correlated gamma-frailty model instead of the shared gamma-frailty
model. This approach allows us to deal with left truncated and right censored lifetime data and
accounts for heterogeneity as well as for an insusceptible (cure) fraction in the study popula-
tion. We perform a simulation study to evaluate the properties of the estimates in the proposed
model and apply it to breast cancer incidence data for 5,857 Swedish female monozygotic and
dizygotic twin pairs from the so-called old cohort of the Swedish Twin Registry. This model
is used to estimate the size of the susceptible fraction and the correlation between the frailties
of the twin partners. Possible extensions, advantages and limitations of the proposed method
are discussed.
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1 Introduction
Models for survival analysis typically assume that everybody in the study population is sus-
ceptible to the event under study and will eventually experience this event if the follow-up is
sufﬁciently long. This is often an unstated assumption of the widely used proportional hazard
models and their extensions - frailty models (for more detailed information about the frailty
concept in the univariate case, see e.g. Vaupel et al. (1979)). However, there are situations
when a fraction of individualsare not expected to experience the event of interest; that is, those
individualsare cured or insusceptible. For example, researchers may be interested in analyzing
the recurrence of a disease. Many individuals may never experience a recurrence; therefore,
a cured fraction of the population exists. Historically, cure models have been utilised to esti-
mate the cured fraction. Cure models are survival models which allow for a cured fraction of
individuals. These models extend the understanding of time-to-event data by allowing for the
formulation of more accurate and informative conclusions. These conclusions are otherwise
unobtainablefrom an analysis which fails to account for a cured or insusceptiblefraction of the
population. If a cured component is not present, the analysis reduces to standard approaches
of survival analysis. Use of cure models has been popular for joint modeling of the overall risk
of a disease and the age-at-onset distribution of the diseased individuals (e.g. Farewell 1977,
1982; Kuk and Chen 1992).
In cure models (we use ’cure fraction’ and ’insusceptible fraction’ as interchangeable notions)
the population is divided into two sub-populations so that an individual either is cured with
probability
1
￿
￿, or has a proper survival function
S
0
(
t
), with probability
￿. A model for the
distribution of survival times that incorporates a cured fraction is given by
S
(
t
)
=
(
1
￿
￿
)
+
￿
S
0
(
t
)
:
Traditional cure models assume that those individuals experiencing the event of interest are
homogeneous in risk. During the last ﬁfteen years, extensions of cure models were developed
in order to allow for heterogeneity among the fraction under risk by using frailty models where
the frailty distribution is a mixture of a discrete and a continuous part (e.g. Aalen 1988,
1992; Longini and Halloran 1996). The frailty mixture distribution has point mass at zero
with probability
1
￿
￿ while heterogeneity among those experiencing the event of interest is4 A. Wienke, P. Lichtenstein, A.I. Yashin
modeled via a continuous distribution with probability
￿. In the gamma frailty mixture model
the survival function is given by
S
(
t
)
=
(
1
￿
￿
)
+
￿
(
1
+
￿
2
H
0
(
t
)
)
￿
1
=
￿
2
:
Here
H
0 denotes the integrated baseline hazard function related to
S
0
(
t
). Price and Manatunga
(2001) gave a good introduction into this area and applied leukemia remission data to different
cure, frailty and frailty cure models. They conclude that frailty models are useful in modeling
data with a cured fraction and found that the gamma frailty cure model provides a better ﬁt to
their remission data compared to the standard cure model.
Chatterjee and Shih (2001) considered an extension of such univariate frailty cure models to
a bivariate setting. They used three different copulas in their two-step analysis procedure. We
suggest the use of the copula of the correlated gamma-frailty model (an extension of Clay-
ton’s shared gamma-frailty model) and show by using simulations that all the parameters are
estimable in a one-step ML estimation procedure.
In the next section we describe the proposed model, then provide an application of the model
to breast cancer data from the Swedish Twin Registry in section three. This is followed by a
results section. In section ﬁve we perform a simulation study to show the identiﬁability and
the performance of the proposed method. The paper concludes with a discussion of further
applications, drawbacks and advantages of the model.
2 Statistical Methods
Our approach is motivatedby the paper of Chatterjee and Shih (2001). We deﬁne an individual
as susceptibleif he/shewilleventuallydevelopthe diseaseif followed-upfor a sufﬁcientlylong
time. For a pair of individuals,
j
=
1
;
2, deﬁne
Y
j
=
8
<
:
1 if the
j th individual is susceptible
0 otherwise
(1)
and use
T
￿
j for the age of onset for the
jth individual when
Y
j
=
1. Furthermore, let
￿
j
=
P
(
Y
j
=
1
) and
S
j
(
t
)
= P
(
T
￿
j
>
t
j
Y
j
=
1
) describe the marginal distribution of
Y
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failure time
T
￿
j for the susceptible individuals, respectively. Because of the symmetry in the
twin data used as an example later on, we assume
￿
1
=
￿
2 and
S
1
(
t
)
=
S
2
(
t
).
Chatterjee and Shih (2001) used three different copulas - Clayton’s model, Frank’s model and
the positive stable model - to specify the dependency structure between the failure times of
two susceptible individuals. Here we use an extension of Clayton’s model (better known as
the shared gamma-frailty model). Clayton’s model is given by
S
(
t
1
;
t
2
)
=
8
<
:
￿
S
(
t
1
)
￿
￿
2
+
S
(
t
2
)
￿
￿
2
￿
1
￿
￿
1
￿
2 if
￿
2
>
0
S
(
t
1
)
S
(
t
2
) if
￿
2
=
0
(2)
where
S
(
t
) denotes the marginal univariate survival function, assumed to be equal for both
partners in a twin pair.
Shared frailty explainscorrelations withinclusters (here twin sib-ships). However, it does have
somelimitations. First, it forces the unobservedfactors to be thesame withinthecluster, which
is not generally reasonable. For example, sometimes it may be inappropriate to assume that
both twin partners share all their unobserved risk factors. Second, the dependence between
survival times within the cluster is based on marginal distributions of survival times. To see
this, when covariates are present in a proportional hazards model with gamma distributed
frailty, the dependence parameter and the population heterogeneity are confounded (Clayton
and Cuzick, 1985), implying that the joint distribution can be identiﬁed from the marginal
distributions(Hougaard, 1986). Elbers and Ridder (1982) show thatthis problemexistsfor any
univariate frailty distribution which has a ﬁnite mean. Third, in most cases univariate frailty
will only induce positive association within the cluster. However, there are some situations
that the survival times for subjects within the same cluster are negatively associated.
To avoid all these limitations, correlated frailty models (Yashin and Iachine, 1994; 1995;
Yashin et al. 1995; Pickles et al., 1994; Commenges and Jacmin-Gadda, 1997; Petersen,
1998; Wienke et al., 2002) are developed for the analysis of multivariate failure time data,
in which two associated random variables are used to characterise the frailty effect for each
cluster. For example, one random variable is assigned for twin 1 and another for twin 2 so
that they would no longer be constrained to have a common frailty. These two variables are
associated and jointly distributed, therefore, knowing one of them does not necessarily imply
the other.6 A. Wienke, P. Lichtenstein, A.I. Yashin
In the following we apply the correlated gamma-frailty model including an insusceptible frac-
tion to ﬁt bivariate time-to-event (occurrence of breast cancer) data. The correlated gamma-
frailty model provides a speciﬁc parameter for correlation between the two frailties. The in-
teresting point here is that individual frailties in twin pairs could not be observed, but their
correlation could be estimated by application of the correlated gamma-frailty model.
The bivariate survival function is given by
S
(
t
1
;
t
2
)
=
8
<
:
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(
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￿
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>
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2
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￿
2
=
0or
￿
=
0
(3)
where
S
(
t
) denotes the marginal univariate survival function, assumed to be equal for both
partners in a twin pair and
0
￿
￿
￿
1 holds. Obviously, the shared gamma-frailty model (2) is
a special case of (3) when
￿
=
1holds.
We use a parametric approach by ﬁtting a Gamma-Gompertz model to the data, e.g.
S
(
t
)
=
￿
1
+
￿
2
￿
￿
(
e
￿
t
￿
1
)
￿
￿
1
￿
2
;
where
￿
;
￿
;
￿
2
;
￿are the parameters to be estimated.
Let
(
X
1
1
;
X
1
2
)
;
:
:
:
;
(
X
n
1
;
X
n
2
)beindependentandidenticallydistributed(i.i.d.) non-negative
two-dimensional random vectors (pairs of lifetimes). The lifetimes
(
X
i
1
;
X
i
2
) are assumed to
be independently censored from the right by i.i.d. pairs of non-negative random variables
(
C
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C
1
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:
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). Thus, instead of
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) (4)
with
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i
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=
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f
X
i
j
;
C
i
j
g,
￿
i
j
=
1
(
X
i
j
￿
C
i
j
)
(
i
=
1
;
:
:
:
;
n
;
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1
;
2
), where
1
(
￿
) denotes
the indicator function of the event in the brackets. The likelihood function of the data in (4) is
given by Chatterjee and Shih (2001):
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where
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).
As mentioned above, the twin pair data set used is not randomly selected from the total twin
population. Since both members of a twin pair had to remain alive in 1958 to be included in
the study population, the survival times are sampled from speciﬁc conditional distributions.
If a twin pair was born in year
y (where
y=1886, ... ,1925), the condition of survival of both
twins until the year 1958 implies that both twins had to survive until 1958-
y in order to be
included in the sample. If the survival times are denoted by
T
1 and
T
2 with survival function
S
(
t
1
;
t
2
), then the conditional survival function for a twin pair born in year
y is:
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y
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5
8
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y
)
:
Consequently, the likelihood function of bivariate left truncated and right censored lifetime
data is given by
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:
For a combined analysis of monozygotic and dizygotic twins we include two correlation co-
efﬁcients,
￿
M
Z and
￿
D
Z, respectively. These correlations between monozygotic and dizygotic
twins provide information about genetic and environmental inﬂuences on frailty within indi-
viduals.
3 Breast cancer data of Swedish twins
Breast cancer incidence data of identical (MZ) and fraternal (DZ) female twins were provided
by the Swedish Twin Registry. This was founded in the years 1959-61 as the world’s largest8 A. Wienke, P. Lichtenstein, A.I. Yashin
nation-wide twin registry and has been continually developed ever since. This population-
based registry includes all (traced) twins born in Sweden in the period 1886-1990. We restrict
our analysis to the so-called old cohort (born 1886-1925) because of small numbers in the
middle cohort. The old cohort consists of all same-sex twin pairs with both individuals alive
whentheregistrywasestablishedin1959-61. Thedatasetwascreated bymergingtheSwedish
Twin Registry with the Swedish Cancer Registry maintained by the National Board of Health
and Welfare. At the time of record linkage, the Swedish Cancer Registry contained all cases
of cancer that were diagnosed during the period from 1959 through 2000.
The church registers from all parishes of the relevant time period were manually checked to
identify all twin births. In 1959-61 a questionnaire was sent to all twins including a question
about phenotypicsimilaritiestoassess the zygosity(Where youas childrenas alike as twopeas
in a pod?). When both partners agreed, they were deﬁned as MZ twins. This zygosity classiﬁ-
cation was compared with laboratory methods. The misclassiﬁcation rate for this method was
found to be very low (Cederl¨ of et al., 1961).
The data set provided by the Swedish Twin Registry contains records of 5,857 female twin
pairs with both partners alive in 1959-61. Consequently, lifetimes are bivariate left trun-
cated. Individuals were followed from 1959-61 to October 27, 2000. Altogether, we have
2,003 monozygotic twin pairs and 3,854 dizygotic twin pairs and 715 cases of breast cancer
were identiﬁed during the follow-up. More detailed information about the composition of the
Swedish Twin Registry can be found in Lichtenstein et al. (2002). Mortality in the study pop-
ulation was determined by linkage to the Mortality Registry of Statistics, Sweden. Analysis
was made with SPSS and GAUSS.
concordant pairs discordant pairs concordance rate
MZ twins 18 218 0.14
DZ twins 27 407 0.12
Table 1: Probandwise concordances for breast cancerUnobserved heterogeneity in a model with cure fraction applied to breast cancer 9
4 Results
Applying the correlated frailty model with and without the cure fraction to the breast cancer
data described above yields the results given in Table 2. We consider two different cases of
cure models. In the ﬁrst case we assume that the susceptible status of the individuals in a twin
pair is independent of each other, e.g. P
(
Y
1
=
p
1
;
Y
2
=
p
2
)
= P
(
Y
1
=
p
1
)P
(
Y
2
=
p
2
) with
p
1
;
p
2
2
f
0
;
1
g. In that case the cure fraction isuniquelydescribedby the univariateprobability
￿
= P
(
Y
1
=
1
)
=P
(
Y
2
=
1
) , whichresultsin
￿
1
1
=
￿
2,
￿
1
0
=
￿
0
1
=
￿
(
1
￿
￿
),
￿
0
0
=
(
1
￿
￿
)
2.
In the second case, which is an extension of the ﬁrst one, we relax the above restriction of
independence between the susceptibility status of the two partners in a pair and use the weaker
constraints
￿
1
0
=
￿
0
1,
￿
1
1
+
￿
1
0
+
￿
0
1
+
￿
0
0
=
1 . Comparing the likelihood of the two it turns
out that the cure model with the independent susceptible status of the twin partners shows a
signiﬁcantly better ﬁt than the model without the cure fraction (
￿
2
1
=
4
:
3
2
;
p
=
0
:
0
4). The
more complicated cure model without the independence assumption between the susceptible
status of the twin partners shows no signiﬁcant improvement compared with the cure model
assuming independence (
￿
2
1
=
0
:
2
3
;
p
=
0
:
6
3).
without cure fraction with cure fraction
1 with cure fraction
2
Parameter estimates (std) estimates (std) estimates (std)
￿ 1.31
￿
1
0
￿
5 (1.04
￿
1
0
￿
5) 7.64
￿
1
0
￿
5 (4.84
￿
1
0
￿
5) 1.175
￿
1
0
￿
5 (1.170
￿
1
0
￿
5)
￿ 0.099 (0.016) 0.091 (0.012) 0.086 (0.015)
￿ 5.736 (0.680) 2.107 (0.406) 1.576 (0.951)
￿
M
Z 0.154 (0.052) 1.000 ( - ) 1.000 ( - )
￿
D
Z 0.125 (0.040) 0.934 (0.361) 0.962 (0.457)
￿
1
1 1.000 ( - ) 0.049 ( - ) 0.038 (0.021)
￿
1
0 0.000 ( - ) 0.173 ( - ) 0.133 (0.058)
￿
0
0 0.000 ( - ) 0.605 ( - ) 0.696 (0.136)
￿ 1.000 ( - ) 0.222 (0.045) 0.171
3 (-)
likelihood 5122.7020 5120.5408 5120.4237
Table 2: Results of breast cancer data with correlated gamma-frailty model without and with cured
fraction.
1 constrained by
￿
1
1
=
￿
2,
￿
1
0
=
￿
0
1
=
￿
(
1
￿
￿
),
￿
0
0
=
(
1
￿
￿
)
2,
2 constrained by
￿
1
0
=
￿
0
1,
￿
1
1
+
￿
1
0
+
￿
0
1
+
￿
0
0
=
1 ,
3 calculated by
￿
=
￿
1
1
+
￿
1
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5 Simulations
All simulations involve generating gamma-distributed frailties, bivariate lifetimes, censoring
and truncation times as well as the inclusion of a cured fraction in the study population. We
will try to mimic the characteristics of the Swedish twin data which we analyzed in the pre-
vious example. A total of 6,500 twin pairs are simulated, a number which is reduced by the
truncation process to a ﬁnal sample size of around 5,700 twin pairs. Samples are generated as
follows:
￿ Generate frailty variables using independent gamma-distributed random variables.
￿ Generate lifetimes given the frailties using
S
(
t
j
Z
)
=
e
￿
Z
￿
￿
(
e
￿
t
￿
1
).
￿ Deﬁne cured individuals by using a random variable.
￿ The censored (bivariate) lifetimes are generated by using the year 2000 as the end of the
study.
￿ Birth years are generated by using a uniform distribution on [1886,1925] to mimic the
truncation pattern. The year of truncation is 1958.
The simulated data were generated assuming independence between the susceptibility status
of the partners (second column in Table 2), but in the estimation procedure the more gen-
eral model with a dependent susceptibility status was applied (third column in Table 2). We
simulated 1,000 data sets.
Parameter true value Mean of estimates standard deviation
￿ 1
￿
1
0
￿
5 1.16
￿
1
0
￿
5 6.70
￿
1
0
￿
6
￿ 0.120 0.120 0.010
￿ 2.000 2.016 0.270
￿ 0.600 0.606 0.132
￿
1
1 0.160 0.164 0.027
￿
1
0 0.240 0.241 0.014
￿
0
0 0.360 0.354 0.046
Table 3: Parameter estimation in the simulation study.Unobserved heterogeneity in a model with cure fraction applied to breast cancer 11
The mean parameter estimates of the model are shown in Table 3, in comparison with the true
values used for simulation. There appears to be nearly no bias in the parameter estimates, and
the overall performance is quite accurate.
6 Discussion
In this paper we have suggested a cure-mixture model for the modeling of correlations in bi-
variate time-to-eventdata. This model extends the approach outlinedin the paper of Chatterjee
and Shih (2001) in various ways. First, instead of the shared gamma-frailty model we use the
much more ﬂexible correlated gamma-frailty model, which includes the shared gamma-frailty
model as a special case. Second, we propose to use a direct estimation procedure in the para-
metric model instead of the two-step estimation procedure used by Chatterjee and Shih. Third,
we think that our twin data are more appropriate as an illustrativeexample than the family data
of Chatterjee and Shih (who ignored higher order correlations in their family data) for such
bivariate models. Nevertheless, our estimate of the size of a susceptible fraction (due to breast
cancer) with 0.222 (0.045) is very close to the estimate 0.22 (0.0093) in the parametric model
found by Chatterjee and Shih in a completely different study population. Furthermore, this
ﬁnding is in line with the results of Peto and Mack (2002). Fourth, we allow the lifetimes to
be truncated in our model.
Cure models with the right censored observations suffer from an inherent identiﬁability prob-
lem. For such observations the event under study has not occurred either because the person is
insusceptible, or because the person is susceptible but follow-up was not long enough for the
event to be observed. The identiﬁability problem increased with increasing censoring, but is
lessened by the parametric modeling of the baseline hazard. The simulation study shows that
the estimation procedure works well under the given truncation and censoring scheme in our
sample data set. Stronger right censoring causes strong identiﬁability problems. For example,
in an additional simulation study (not shown here) using the same parameters as described
in the simulation section but using the birth years 1926-1958 (which is the situation in the
so-called middle cohort of the Swedish Twin Registry) resulted in a complete breakdown of
the estimation procedure. In cure models with ﬁxed censoring times (caused by the end of the
study) censoring is no longer non-informative even when the censoring times and the survival
times are independent. The proportion of censored observations contains important informa-12 A. Wienke, P. Lichtenstein, A.I. Yashin
tion about parameters in the model. For example, in the (usually ideal) case of no censoring,
it holds
￿
=
1 .
The present paper is restricted to the parametric case, meaning in our case the marginal sur-
vival function is speciﬁed parametrically up to a few (one-dimensional) parameters,
S
(
t
)
=
￿
1
+
￿
2
￿
￿
(
e
￿
t
￿
1
)
￿
￿
1
￿
2 with Gompertz parameters
￿ and
￿. From a statistical point of view
such a parametric assumption is unsatisfactory, because it is non-justiﬁable. Frailty models
of univariate data have been strongly criticised because assumptions have to be made about
both the shape of the underlying mortality trajectory and the distribution of the frailty: differ-
ent pairs of assumptions can result in equally good ﬁts to the data. Without an insusceptible
fraction in the population (
￿
=
1) this problem can be solved by using the non-parametric
correlated gamma-frailty model (Yashin and Iachine, 1995). Applying the (true) parametric
and semi-parametric estimation procedures to the same (simulated) data generated from the
correlated gamma-frailty model, the semi-parametric estimation procedure shows good per-
formance, despite the fact that it does not make use of the additional information about the
parametric structure of the marginal survival functions. The estimates of
￿
2 and
￿ are similar
in both cases (results are not shown here). Nevertheless, using the wrong parametric model
may result in biased parameter estimates.
To what extent thismethod is applicable in the much more complicatedsemi-parametric model
with cure fraction is still an open question, one that needs further careful consideration. Deal-
ing with a disease with late age of onset resulting in heavily censored data may lead to prob-
lems in estimating the (inﬁnite dimensional) nuisance parameter - the marginal survival func-
tion - and, consequently, in estimating the parameters of interest,
￿
2 and
￿.
Our study points to the existence of an important insusceptible fraction. The suggested model
givesa clear illustrationof how survivalanalysis and cure models could be merged for analysis
of time-to-event data of related individuals.
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